|
AP20730a-ev
|
Abcepta, Inc.
|
C1QBP [N-term] [RB48595], Rabbit Polyclonal Antibody
|
Human
|
WB
|
|
|
AP20730a
|
Abcepta, Inc.
|
C1QBP [N-term] [RB48595], Rabbit Polyclonal Antibody
|
Human
|
WB
|
|
|
HY-W142092-10mg
|
MedChemexpress LLC
|
N-Acetyl-DL-serine [CAS 97-14-3]
|
|
|
|
|
HY-W142092-100mg
|
MedChemexpress LLC
|
N-Acetyl-DL-serine [CAS 97-14-3]
|
|
|
|
|
HY-W142092-25mg
|
MedChemexpress LLC
|
N-Acetyl-DL-serine [CAS 97-14-3]
|
|
|
|
|
HY-W142092-50mg
|
MedChemexpress LLC
|
N-Acetyl-DL-serine [CAS 97-14-3]
|
|
|
|
|
HY-111071-100mg
|
MedChemexpress LLC
|
Nilofabicin [CAS 934628-27-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-111071-50mg
|
MedChemexpress LLC
|
Nilofabicin [CAS 934628-27-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-B1924-1mg
|
MedChemexpress LLC
|
Norvancomycin (hydrochloride) [CAS 213997-73-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-B1924-10mg
|
MedChemexpress LLC
|
Norvancomycin (hydrochloride) [CAS 213997-73-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-B1924-100mg
|
MedChemexpress LLC
|
Norvancomycin (hydrochloride) [CAS 213997-73-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-B1924-5mg
|
MedChemexpress LLC
|
Norvancomycin (hydrochloride) [CAS 213997-73-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-B1924-50mg
|
MedChemexpress LLC
|
Norvancomycin (hydrochloride) [CAS 213997-73-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-B1924-1mL
|
MedChemexpress LLC
|
Norvancomycin (hydrochloride) [CAS 213997-73-0] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-P2358-1mg
|
MedChemexpress LLC
|
PSMAlpha3 [CAS 1001405-52-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-P2358-10mg
|
MedChemexpress LLC
|
PSMAlpha3 [CAS 1001405-52-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-P2358-5mg
|
MedChemexpress LLC
|
PSMAlpha3 [CAS 1001405-52-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-P99583-1mg
|
MedChemexpress LLC
|
Suvratoxumab [CAS 1629620-18-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-P99583-10mg
|
MedChemexpress LLC
|
Suvratoxumab [CAS 1629620-18-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-P99583-5mg
|
MedChemexpress LLC
|
Suvratoxumab [CAS 1629620-18-3]
|
|
COVID-19-immunoregulation
|
|
|
5370-0002
|
LGC SeraCare - KPL
|
BacTrace Salmonella typhimurium, Positive Control (50-74-01)
|
Salmonella typhimurium
|
Positive Control
|
|
|
5370-0007
|
LGC SeraCare - KPL
|
BacTrace Staphylococcus aureus, Positive Control (50-90-05)
|
Staphylococcus aureus
|
Positive Control
|
|
|
5220-0376
|
LGC SeraCare - KPL
|
Protein A, Peroxidase labeled (14-50-00)
|
|
|
|
|
MD-05-0452
|
RayBiotech, Inc.
|
Mouse anti-S. aureus Enterotoxin B
|
Bacterial, Staphylococcus aureus
|
Detection of staphylococcal enterotoxins in ELISA.
|
|
|
OPSA10596
|
Aviva Systems Biology
|
NATIVE STAPHYLOCOCCUS AUREUS PROTEIN A Protein
|
|
|
|
